1. Home
  2. PVLA vs MERC Comparison

PVLA vs MERC Comparison

Compare PVLA & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • MERC
  • Stock Information
  • Founded
  • PVLA 2015
  • MERC 1968
  • Country
  • PVLA United States
  • MERC Canada
  • Employees
  • PVLA N/A
  • MERC N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • MERC Paper
  • Sector
  • PVLA Health Care
  • MERC Basic Materials
  • Exchange
  • PVLA Nasdaq
  • MERC Nasdaq
  • Market Cap
  • PVLA 253.2M
  • MERC 271.5M
  • IPO Year
  • PVLA N/A
  • MERC 1987
  • Fundamental
  • Price
  • PVLA $24.45
  • MERC $3.59
  • Analyst Decision
  • PVLA Strong Buy
  • MERC Hold
  • Analyst Count
  • PVLA 7
  • MERC 3
  • Target Price
  • PVLA $46.29
  • MERC $5.33
  • AVG Volume (30 Days)
  • PVLA 52.4K
  • MERC 707.8K
  • Earning Date
  • PVLA 05-15-2025
  • MERC 05-01-2025
  • Dividend Yield
  • PVLA N/A
  • MERC 8.37%
  • EPS Growth
  • PVLA N/A
  • MERC N/A
  • EPS
  • PVLA N/A
  • MERC N/A
  • Revenue
  • PVLA N/A
  • MERC $1,996,904,000.00
  • Revenue This Year
  • PVLA N/A
  • MERC $2.43
  • Revenue Next Year
  • PVLA N/A
  • MERC $6.12
  • P/E Ratio
  • PVLA N/A
  • MERC N/A
  • Revenue Growth
  • PVLA N/A
  • MERC N/A
  • 52 Week Low
  • PVLA $11.17
  • MERC $3.20
  • 52 Week High
  • PVLA $29.27
  • MERC $9.78
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • MERC 34.30
  • Support Level
  • PVLA N/A
  • MERC $3.47
  • Resistance Level
  • PVLA N/A
  • MERC $4.22
  • Average True Range (ATR)
  • PVLA 0.00
  • MERC 0.17
  • MACD
  • PVLA 0.00
  • MERC 0.03
  • Stochastic Oscillator
  • PVLA 0.00
  • MERC 14.67

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.

Share on Social Networks: